Article

Congress Fights DIR Fees Highlights SPT Week in Review

Author(s):

Top news of the week from Specialty Pharmacy Times.

5. Transcranial Direct Current Stimulation Reduces Fatigue in Multiple Sclerosis

An estimated 75% of patients with multiple sclerosis report fatigue among their most disabling disease symptoms. Read more.

4. Adherence in a Nutshell

Non-adherence to medication regimens is estimated to cost approximately $290 billion dollars in unnecessary medical expenses. Read more.

3. Independent Oncology Practices Could Lower Health Care Costs

Cancer care at hospitals is significantly more expensive than at community oncology clinics. Read more.

2. Specialty Pharmacies Poised to Connect Ovarian Cancer Patients with Crucial Services

Patients with ovarian cancer often face complex burdens that go beyond just medication. Read more.

1. Congress Urges HHS, CMS to Terminate DIR Fees

Legislators are becoming more informed about DIR fees and their harms on Medicare beneficiaries and specialty pharmacies. Read more.

Related Videos
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
Image Credit: © Krakenimages.com - stock.adobe.com
Image Credit: © Cavan - stock.adobe.com
Child with cancer -- Image credit: Alexis Scholtz/peopleimages.com | stock.adobe.com
Image Credit: © Rawpixel.com - stock.adobe.com
Image Credit: © RandyJay - stock.adobe.com
WCLC, lung cancer, NSCLC
MARIPOSA Study: Long-Term Outcomes and Next Steps for Amivantamab Plus Lazertinib in EGFR-Mutant NSCLC
The EMPOWER-Lung 1 Trial: Five-Year Outcomes of Cemiplimab Monotherapy in Advanced NSCLC